MansoorNSalehMD

Clinical Trials

• Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma Start of enrollment: 1997 Jun 01

  Completed

  Phase 1

• ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer Start of enrollment: 1999 Jan 01

  Terminated

  Phase 2

• Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 1999 Nov 01

  Completed

  Phase 2

• Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer Start of enrollment: 2007 Aug 15

  Completed

  Phase 2

• Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01

  Active, not recruiting

  Phase 3

• Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11

  Terminated

  Phase 3

• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02

  Completed

• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07

  Completed

  Phase 2

• Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Start of enrollment: 2011 Sep 30

  Terminated

  Phase 1, Phase 2

• A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2012 Oct 01

  Completed

  Phase 1, Phase 2

• A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2012 Oct 31

  Completed

  Phase 2

• A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors Start of enrollment: 2012 Nov 01

  Completed

  Phase 1

• A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12

  Completed

  Phase 2

• Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14

  Terminated

  Phase 2

• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17

  Completed

  Phase 3

• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01

  Completed

  Phase 2

• Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment Start of enrollment: 2014 Apr 01

  Completed

  Phase 2

• A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma Start of enrollment: 2015 Jan 01

  Completed

  Phase 1, Phase 2

• A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents Start of enrollment: 2016 Oct 21

  Completed

  Phase 1

• An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies Start of enrollment: 2017 May 25

  Terminated

  Phase 1

• Join now to see all